Stanley Schrier

Hematologist, Medical oncologist

Professor of Medicine (Hematology), Emeritus

Hematology Program

  • 875 Blake Wilbur Drive
  • Palo Alto, CA 94304
  • Phone: 650-498-6000
Learn More About the Clinic Getting Here Make An Appointment

Amyloid Center

  • 300 Pasteur Drive
  • Stanford, CA 94305
  • Phone: 650-725-6186
Learn More About the Clinic Getting Here Make An Appointment

Professional Education

Internship: Johns Hopkins University School of Medicine (1955) MD

Board Certification: Hematology, American Board of Internal Medicine (1976)

Board Certification: Internal Medicine, American Board of Internal Medicine (1961)

Residency: University of Chicago Hospitals (1959) IL

Residency: University of Michigan School of Public Health (1956) MI

Medical Education: Johns Hopkins University School of Medicine (1954) MD

Clinical Trials

Clinical trials are research studies that evaluate a new medical approach, device, drug, or other treatment. As a Stanford Health Care patient, you may have access to the latest, advanced clinical trials.

Open trials refer to studies currently accepting participants. Closed trials are not currently enrolling, but may open in the future.

The prognostic value of diagnosing concurrent multiple myeloma in immunoglobulin light chain amyloidosis
Dinner, S., Witteles, W., Witteles, R., Lam, A., Arai, S., & Liedtke, M. (2013). The prognostic value of diagnosing concurrent multiple myeloma in immunoglobulin light chain amyloidosis. BRITISH JOURNAL OF HAEMATOLOGY, 161(3), 367-372.

Hematopoietic stem cell and progenitor cell mechanisms in myelodysplastic syndromes
Pang, W. W., Pluvinage, J. V., Price, E. A., Sridhar, K., Arber, D. A., & Weissman, I. L. (2013). Hematopoietic stem cell and progenitor cell mechanisms in myelodysplastic syndromes. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 110(8), 3011-3016.

What does the spleen see?
Schrier, S. L. (2012). What does the spleen see?. Blood, 120(2), 242-243.

Anemia in the elderly
Pang, W. W., & Schrier, S. L. (2012). Anemia in the elderly. CURRENT OPINION IN HEMATOLOGY, 19(3), 133-140.

Heart transplantation and cardiac amyloidosis: Approach to screening and novel management strategies
Varr, B. C., Liedtke, M., Arai, S., Lafayette, R. A., Schrier, S. L., & Witteles, R. M. (2012). Heart transplantation and cardiac amyloidosis: Approach to screening and novel management strategies. JOURNAL OF HEART AND LUNG TRANSPLANTATION, 31(3), 325-331.

Human bone marrow hematopoietic stem cells are increased in frequency and myeloid-biased with age
Pang, W. W., Price, E. A., Sahoo, D., Beerman, I., Maloney, W. J., & Weissman, I. L. (2011). Human bone marrow hematopoietic stem cells are increased in frequency and myeloid-biased with age. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 108(50), 20012-20017.

Anemia in older persons: Etiology and evaluation
Price, E. A., Mehra, R., Holmes, T. H., & Schrier, S. L. (2011). Anemia in older persons: Etiology and evaluation. BLOOD CELLS MOLECULES AND DISEASES, 46(2), 159-165.

To be old is to be inflamed?
Schrier, S. L. (2010). To be old is to be inflamed?. BLOOD, 115(18), 3651-3652.

Unexplained aspects of anemia of inflammation.
Price, E. A., & Schrier, S. L. (2010). Unexplained aspects of anemia of inflammation. Advances in hematology, 2010, 508739-?.

Anemia in the elderly: Introduction
Price, E. A., & Schrier, S. L. (2008). Anemia in the elderly: Introduction. SEMINARS IN HEMATOLOGY, 45(4), 207-209.

Lung cancer presenting with amegakaryocytic thrombocytopenia.
Witteles, W. H., Schrier, S. L., & Wakelee, H. A. (2008). Lung cancer presenting with amegakaryocytic thrombocytopenia. Journal of clinical oncology , 26(7), 1171-1174.

VEGF modulates erythropoiesis through regulation of adult hepatic erythropoietin synthesis
Tam, B. Yy., Wei, K., Rudge, J. S., Hoffman, J., Holash, J., & Kuo, C. J. (2006). VEGF modulates erythropoiesis through regulation of adult hepatic erythropoietin synthesis. NATURE MEDICINE, 12(7), 793-800.

New strategies in the treatment of the thalassemias
Schrier, S. L., & Angelucci, E. (2005). New strategies in the treatment of the thalassemias. ANNUAL REVIEW OF MEDICINE, 56, 157-171.

The HP1L1-PDIGFR alpha fusion tyrosine kinase in hypereosinophilic syndrome and chronic eosinophilic leukemia: implications for diagnosis, classification, and management
Gotlib, J., Cools, J., Malone, J. M., Schrier, S. L., Gilliland, D. G., & Coutre, S. E. (2004). The HP1L1-PDIGFR alpha fusion tyrosine kinase in hypereosinophilic syndrome and chronic eosinophilic leukemia: implications for diagnosis, classification, and management. BLOOD, 103(8), 2879-2891.

The role of oxidant injury in the pathophysiology of human thalassemias
Schrier, S. L., Centis, F., Verneris, M., Ma, L., & Angelucci, E. (2003). The role of oxidant injury in the pathophysiology of human thalassemias. REDOX REPORT, 8(5), 241-245.

Pathophysiology of thalassemia
Schrier, S. L. (2002). Pathophysiology of thalassemia. CURRENT OPINION IN HEMATOLOGY, 9(2), 123-126.

Pathophysiology of the thalassemias the Albion Walter Hewlett Award presentation
Schrier, S. L. (1997). Pathophysiology of the thalassemias the Albion Walter Hewlett Award presentation. WESTERN JOURNAL OF MEDICINE, 167(2), 82-89.

Improved perfusion with rt-PA and hirulog in a rabbit model of embolic stroke
Yenari, M. A., deCrespigny, A., Palmer, J. T., Roberts, S., Schrier, S. L., & Steinberg, G. K. (1997). Improved perfusion with rt-PA and hirulog in a rabbit model of embolic stroke. JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM, 17(4), 401-411.

The unusual pathobiology of hemoglobin constant spring red blood cells
Schrier, S. L., Bunyaratvej, A., KHUHAPINANT, A., Fucharoen, S., Aljurf, M., & Mohandas, N. (1997). The unusual pathobiology of hemoglobin constant spring red blood cells. BLOOD, 89(5), 1762-1769.

Pathobiology of thalassemic erythrocytes.
Schrier, S. L. (1997). Pathobiology of thalassemic erythrocytes. Current opinion in hematology, 4(2), 75-78.

THALASSEMIA - PATHOPHYSIOLOGY OF RED-CELL CHANGES
Schrier, S. L. (1994). THALASSEMIA - PATHOPHYSIOLOGY OF RED-CELL CHANGES. ANNUAL REVIEW OF MEDICINE, 45, 211-218.

TRANSMEMBRANE REDISTRIBUTION OF PHOSPHOLIPIDS OF THE HUMAN RED-CELL MEMBRANE DURING HYPOTONIC HEMOLYSIS
Schrier, S. L., Zachowski, A., Herve, P., Kader, J. C., & Devaux, P. F. (1992). TRANSMEMBRANE REDISTRIBUTION OF PHOSPHOLIPIDS OF THE HUMAN RED-CELL MEMBRANE DURING HYPOTONIC HEMOLYSIS. BIOCHIMICA ET BIOPHYSICA ACTA, 1105(1), 170-176.

GLOBIN-CHAIN SPECIFICITY OF OXIDATION-INDUCED CHANGES IN RED-BLOOD-CELL MEMBRANE-PROPERTIES
Schrier, S. L., & Mohandas, N. (1992). GLOBIN-CHAIN SPECIFICITY OF OXIDATION-INDUCED CHANGES IN RED-BLOOD-CELL MEMBRANE-PROPERTIES. BLOOD, 79(6), 1586-1592.

OXIDATIVE RED-BLOOD-CELL MEMBRANE INJURY IN THE PATHOPHYSIOLOGY OF SEVERE MOUSE BETA-THALASSEMIA
Advani, R., Rubin, E., Mohandas, N., & Schrier, S. L. (1992). OXIDATIVE RED-BLOOD-CELL MEMBRANE INJURY IN THE PATHOPHYSIOLOGY OF SEVERE MOUSE BETA-THALASSEMIA. BLOOD, 79(4), 1064-1067.

CHARACTERIZATION AND COMPARISON OF THE RED-BLOOD-CELL MEMBRANE DAMAGE IN SEVERE HUMAN ALPHA-THALASSEMIA AND BETA-THALASSEMIA
Advani, R., Sorenson, S., Shinar, E., LANDE, W., Rachmilewitz, E., & Schrier, S. L. (1992). CHARACTERIZATION AND COMPARISON OF THE RED-BLOOD-CELL MEMBRANE DAMAGE IN SEVERE HUMAN ALPHA-THALASSEMIA AND BETA-THALASSEMIA. BLOOD, 79(4), 1058-1063.

MECHANISMS OF AMPHIPATH-INDUCED STOMATOCYTOSIS IN HUMAN ERYTHROCYTES
Schrier, S. L., Zachowski, A., & Devaux, P. F. (1992). MECHANISMS OF AMPHIPATH-INDUCED STOMATOCYTOSIS IN HUMAN ERYTHROCYTES. BLOOD, 79(3), 782-786.

MYOSIN CONTENT AND DISTRIBUTION IN HUMAN NEONATAL ERYTHROCYTES ARE DIFFERENT FROM ADULT ERYTHROCYTES
COLIN, F. C., & Schrier, S. L. (1991). MYOSIN CONTENT AND DISTRIBUTION IN HUMAN NEONATAL ERYTHROCYTES ARE DIFFERENT FROM ADULT ERYTHROCYTES. BLOOD, 78(11), 3052-3055.

SPONTANEOUS ENDOCYTOSIS IN HUMAN NEONATAL AND ADULT RED-BLOOD-CELLS - COMPARISON TO DRUG-INDUCED ENDOCYTOSIS AND TO RECEPTOR-MEDIATED ENDOCYTOSIS
COLIN, F. C., & Schrier, S. L. (1991). SPONTANEOUS ENDOCYTOSIS IN HUMAN NEONATAL AND ADULT RED-BLOOD-CELLS - COMPARISON TO DRUG-INDUCED ENDOCYTOSIS AND TO RECEPTOR-MEDIATED ENDOCYTOSIS. AMERICAN JOURNAL OF HEMATOLOGY, 37(1), 34-40.

CELLULAR AND MEMBRANE-PROPERTIES OF ALPHA-THALASSEMIC AND BETA-THALASSEMIC ERYTHROCYTES ARE DIFFERENT - IMPLICATION FOR DIFFERENCES IN CLINICAL MANIFESTATIONS
Schrier, S. L., Rachmilewitz, E., & Mohandas, N. (1989). CELLULAR AND MEMBRANE-PROPERTIES OF ALPHA-THALASSEMIC AND BETA-THALASSEMIC ERYTHROCYTES ARE DIFFERENT - IMPLICATION FOR DIFFERENCES IN CLINICAL MANIFESTATIONS. BLOOD, 74(6), 2194-2202.

COMPARISON OF TRANSFERRIN RECEPTOR-MEDIATED ENDOCYTOSIS AND DRUG-INDUCED ENDOCYTOSIS IN HUMAN NEONATAL AND ADULT RBCS
Thatte, H. S., & Schrier, S. L. (1988). COMPARISON OF TRANSFERRIN RECEPTOR-MEDIATED ENDOCYTOSIS AND DRUG-INDUCED ENDOCYTOSIS IN HUMAN NEONATAL AND ADULT RBCS. BLOOD, 72(5), 1693-1700.

SHAPE CHANGES AND DEFORMABILITY IN HUMAN-ERYTHROCYTE MEMBRANES
Schrier, S. L. (1987). SHAPE CHANGES AND DEFORMABILITY IN HUMAN-ERYTHROCYTE MEMBRANES. JOURNAL OF LABORATORY AND CLINICAL MEDICINE, 110(6), 791-797.